The prophylaxis of hereditary angioedema attacks with recombinant human C1 inhibitor: who will take advantage of the individualized treatment approach?

Allergy. 2013 Sep;68(9):1207-9. doi: 10.1111/all.12165.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Complement C1 Inhibitor Protein / therapeutic use*
  • Female
  • Hereditary Angioedema Types I and II / prevention & control*
  • Humans
  • Male
  • Recombinant Proteins / therapeutic use*

Substances

  • Complement C1 Inhibitor Protein
  • Recombinant Proteins